Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors | At Barron’s

Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides “tremendous opportunity for growth.“ This interview was recorded on Jan. 15, 2024, at the World Economic Forum meeting in Davos, Switzerland. SUBSCRIBE ➡️ Visit our website: Follow us on Instagram ➡️ Like us on Facebook ➡️ Follow us on Twitter ➡️ Barron’s is the world’s premier investing publication since 1921. #Barrons #podcast